PolyNovo Limited (CALZF PINK) stock market data APIs
$0.7922
0(0%)
as of July 11, 2025
Try our APIs with
free plan!
PolyNovo Limited Financial Data Overview
Price chart is built with
Anychart
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Prev. Close
0.7922
Open
0.7922
High
0.7922
Low
0.7922
52 wk Range
0.615-1.82
Market Cap
552 M
P/E Ratio
79.9
Shares Outstanding
691 M
Revenue
116 M
EPS
-0.0006
Beta
1.557
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get PolyNovo Limited data using free add-ons & libraries
Get PolyNovo Limited Fundamental Data
PolyNovo Limited Fundamental data includes:
- Net Revenue: 116 M
- EBITDA: 8 683 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
PolyNovo Limited News
New
Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?
While PolyNovo Limited (ASX:PNV) might not have the largest market cap around , it saw a significant share price rise of 55% in the past couple of months on the ASX. The recent rally in share prices h...
PolyNovo Limited (ASX:PNV) Shares Could Be 48% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, PolyNovo fair value estimate is AU$2.95 Current share price of AU$1.55 suggests PolyNovo is potentially 48% undervalued The AU$1.81 analyst pr...
PolyNovo (ASX:PNV) shareholders have earned a 21% CAGR over the last five years
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can make mor...
PolyNovo Limited (ASX:PNV) Is About To Turn The Corner
With the business potentially at an important milestone, we thought we'd take a closer look at PolyNovo Limited's (ASX:PNV) future prospects. PolyNovo Limited develops medical devices in the United St...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
